Investigating how vaccines can induce protective immunity against HIV

Core B: Non-human Primate Core

NIH-funded research Univ of North Carolina Chapel Hill · NIH-11059122

This study is looking at how to create a strong vaccine for HIV/AIDS by learning how certain antibodies are made in young monkeys, which could help us understand how to protect people from the virus for a long time.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill NIH-funded
Lab location1 site (Chapel Hill, United States)
Project IDNIH-11059122 on NIH RePORTER

What this research studies

This research focuses on developing an effective vaccine for HIV/AIDS by studying how broadly neutralizing antibodies (bnAbs) can be induced. It utilizes non-human primates, specifically infant rhesus macaques, to explore the biological factors that influence B cell differentiation and the development of these antibodies. The research employs systems biology approaches to analyze immune responses and the role of the intestinal microbiome in vaccine effectiveness. By understanding these mechanisms, the goal is to create a vaccine that provides long-term protection against HIV.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit from this research include infants and adults at risk for HIV infection.

Not a fit: Patients who are already living with HIV/AIDS may not directly benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of a highly effective HIV vaccine, significantly reducing the incidence of HIV/AIDS.

How similar studies have performed: Previous research has shown promise in developing bnAbs in non-human primates, indicating potential success for this approach.

Where this research is happening

Chapel Hill, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.